The latest CDC FluView report for Week 11 (ending March 21, 2026) shows a preliminary FluSurv-NET cumulative influenza hospitalization rate of 81.6 per 100,000 population—third highest since 2010-2011—driving trader consensus toward the 80–85 bin at 67.5% implied probability, as declining weekly admissions (1.1 per 100,000) and test positivity (11.5%) signal a waning 2025-2026 season dominated by A(H3N2). Forecasts from FluSight predict further national decreases in hospital admissions for Week 12 (ending March 28), likely adding only ~1 per 100,000 to the cumulative total amid falling outpatient respiratory visits below baseline. High pediatric rates (second highest on record) and preliminary data subject to revision underpin modest support for 85–90 (24.8%), while lower bins reflect expectations of no significant rebound. The next FluView update, due imminently, could refine these market-implied odds.
Experimental AI-generated summary referencing Polymarket data · UpdatedFlu Hospitalization Rate Week 12, 2026?
Flu Hospitalization Rate Week 12, 2026?
80–85 84%
90–95 13%
95+ 7.8%
85–90 5.5%
<75
2%
75–80
43%
80–85
84%
85–90
21%
90–95
9%
95+
8%
80–85 84%
90–95 13%
95+ 7.8%
85–90 5.5%
<75
2%
75–80
43%
80–85
84%
85–90
21%
90–95
9%
95+
8%
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Market Opened: Mar 27, 2026, 11:13 AM ET
Resolver
0x69c47De9D...If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Resolver
0x69c47De9D...The latest CDC FluView report for Week 11 (ending March 21, 2026) shows a preliminary FluSurv-NET cumulative influenza hospitalization rate of 81.6 per 100,000 population—third highest since 2010-2011—driving trader consensus toward the 80–85 bin at 67.5% implied probability, as declining weekly admissions (1.1 per 100,000) and test positivity (11.5%) signal a waning 2025-2026 season dominated by A(H3N2). Forecasts from FluSight predict further national decreases in hospital admissions for Week 12 (ending March 28), likely adding only ~1 per 100,000 to the cumulative total amid falling outpatient respiratory visits below baseline. High pediatric rates (second highest on record) and preliminary data subject to revision underpin modest support for 85–90 (24.8%), while lower bins reflect expectations of no significant rebound. The next FluView update, due imminently, could refine these market-implied odds.
Experimental AI-generated summary referencing Polymarket data · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions